Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection--experience with ABO-incompatible cardiac allografting in the baboon.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection--experience with ABO-incompatible cardiac allografting in the baboon.
Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection--experience with ABO-incompatible cardiac allografting in the baboon. Transplantation. 1993 Oct; 56(4):769-77.
View in:
PubMed
subject areas
ABO Blood-Group System
ABO Blood-Group System
Animals
Animals
Azathioprine
Azathioprine
Blood Group Incompatibility
Blood Group Incompatibility
Carbohydrate Conformation
Carbohydrate Conformation
Carbohydrate Sequence
Carbohydrate Sequence
Cyclophosphamide
Cyclophosphamide
Cyclosporine
Cyclosporine
Drug Administration Schedule
Drug Administration Schedule
Graft Rejection
Graft Rejection
Graft Survival
Graft Survival
Heart Transplantation
Heart Transplantation
Infusions, Intravenous
Infusions, Intravenous
Methylprednisolone
Methylprednisolone
Molecular Sequence Data
Molecular Sequence Data
Oligosaccharides
Oligosaccharides
Papio
Papio
Time Factors
Time Factors
Transplantation, Heterotopic
Transplantation, Heterotopic
Transplantation, Homologous
Transplantation, Homologous
authors with profiles
Stanley D Kosanke